Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
about
Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptorsProapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and AktRaf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replicationRegulation of RKIP binding to the N-region of the Raf-1 kinaseThe landscape of targeted therapies for cholangiocarcinoma: current status and emerging targetsRaf-interactome in tuning the complexity and diversity of Raf function.Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5Regulation and role of Raf-1/B-Raf heterodimerization.Upregulation and maintenance of gap junctional communication in lens cellsEndosomal targeting of MEK2 requires RAF, MEK kinase activity and clathrin-dependent endocytosisCell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylationSignal response sensitivity in the yeast mitogen-activated protein kinase cascadeThe potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer.Changed genome heterochromatinization upon prolonged activation of the Raf/ERK signaling pathway.Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway.CNK1 is a scaffold protein that regulates Src-mediated Raf-1 activation.Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signalsPhospholipase D1, but not D2, regulates protein secretion via Rho/ROCK in a Ras/Raf-independent, MEK-dependent manner in rat lacrimal gland.Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers.Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors.Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein.Extracellular-signal regulated kinase 8 of Trypanosoma brucei uniquely phosphorylates its proliferating cell nuclear antigen homolog and reveals exploitable properties.Multiplexing PKA and ERK1&2 kinases FRET biosensors in living cells using single excitation wavelength dual colour FLIM.Phosphatidylenthanolamine Binding Protein aka Raf Kinase Inhibitor Protein: A Brief History of Its Discovery and the Remarkable Diversity of Biological Functions.Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops.p21 activated kinase 5 activates Raf-1 and targets it to mitochondriaTargeting prostate cancer based on signal transduction and cell cycle pathways.Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cellsSpecificity and robustness of the mammalian MAPK-IEG networkA perspective on molecular therapy in cholangiocarcinoma: present status and future directions.Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy."RAF" neighborhood: protein-protein interaction in the Raf/Mek/Erk pathway.The route to personalized medicine in bladder cancer: where do we stand?New Horizons for Precision Medicine in Biliary Tract Cancers.Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway.Measuring ERK Activity Dynamics in Single Living Cells Using FRET Biosensors.
P2860
Q23909443-8279F306-1F9F-4C29-B858-B6DE763714CBQ24296477-E2C4080A-04F9-4E7A-93BF-02DD485D54A6Q24300700-863307B1-7BBC-4667-A4C2-3E44C18312CDQ24314069-E237DB88-5ACC-40AA-935C-31C53AF12D5CQ26751224-95C608C5-3884-43BE-B657-6B1544D20A2DQ27692653-0A64FA5F-1641-4D2A-AE09-F399BB7589F8Q28577191-32184C84-1BDE-48CC-A3DF-57BB457B0177Q28580581-9E0144E1-5129-4FF4-A5C4-EF3AFC923934Q28752600-FC26C804-DCB2-4D1F-9B0D-D3EDD9FDDCFBQ30490506-4D89A403-DED7-4DAB-90BE-1F035CD955D5Q30495932-71AA1135-9714-43D8-B4BE-B60DFED879A6Q33644264-93515A5E-9313-4DBC-9899-AB423726A779Q33656860-19F14B70-D4DB-4711-9A45-C980E6BEB963Q33725691-1B6E71F4-67EB-494B-8556-54970BEE19BDQ33790457-461F1436-D752-4B41-B19C-35BF0564698AQ34413075-4BEFFCA6-5EB0-4EB7-BBA8-8F1725CECD9CQ34442391-F10628F4-4EFB-41A3-9F97-D3DB44561CF3Q34721752-21C07C09-FEAD-49E3-A2DC-A4C735ABDB8EQ34824236-48746CD1-780B-4A41-A5FF-9F95D997DED5Q35023456-D654FFF6-FEB7-4CC6-A80D-6D63C05893F4Q35282099-DF062802-5102-4385-AF81-2811E7ECED4CQ35804449-D478A5A8-84A7-42BC-A16A-C0CAFCCEBA96Q35911472-6C6C22E0-AE6E-48C9-82B4-D05FC09ECB89Q36027352-C274A291-7253-4EF3-B86A-38EAAF178530Q36121762-763734D1-3E62-4041-BFA1-417BF172A312Q36255099-BB6BAD9B-382A-402A-AE64-88B498898FD9Q36452213-4393A0CA-0DED-4DDF-9CEB-A143E6DDB1D8Q36559220-9FFA0BC8-0801-403F-9886-66B778AB9E74Q36953840-8E8CFC21-10EA-4715-8FAF-3AD0604A568BQ36995054-7D89535C-D884-4EF1-9169-98E83AC14E75Q36996036-393AB520-07C6-43B8-BC58-46781260F874Q37263516-9DB345BB-1F81-4768-BCD3-37DA72629510Q37719383-BEC8ED42-5771-436B-804E-7E778CAD9B70Q37865381-B2AA3948-1C2F-4B60-A913-96D12A21047BQ38220879-0A1B3C94-36D0-4048-A9D9-4BCA165D49CEQ38337192-EB3BF8CB-0E09-47CC-99F0-AD399F5F7C5AQ38619219-29B2034A-4A4D-4F23-9946-E3D048F59EF9Q38904172-DA84597D-0039-4E7C-B99E-FF71AA91E625Q39023435-A74CB373-C5AF-4192-8375-B174F9E35AFFQ39125284-820E2930-CD68-4074-9B82-1BE4F5E76187
P2860
Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
@ast
Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
@en
type
label
Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
@ast
Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
@en
prefLabel
Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
@ast
Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
@en
P2860
P921
P356
P1476
Conferring specificity on the ubiquitous Raf/MEK signalling pathway.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601488
P407
P50
P577
2004-01-01T00:00:00Z
2004-01-26T00:00:00Z